Loading...
Dernières publications
-
Lidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, Katerina Kachler, Axel You, et al.. A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine: Nanotechnology, Biology and Medicine, 2023, pp.102635. ⟨10.1016/j.nano.2022.102635⟩. ⟨hal-03885962⟩
-
Alexandra Bayer Wildberger, Cinthia Bergman, Natalia Pinzon, Axel You, Frédérique Truffault, et al.. Immunomodulation capacities of conditioned mesenchymal stromal cells: benefits and mechanisms in an experimental cell therapy approach for Myasthenia gravis. 7th International Myology Congress, Sep 2022, Nice, France. ⟨hal-03824304⟩
Chiffres clés
55
Publications avec texte intégral
Open Access
46 %
Mots clés
Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration
Innate immunity
Interferonopathy
Macrophages
Exercise
Autoimmune disease
Transcriptome
MYB
BAFF
Experimental autoimmune myasthenia gravis EAMG
Germinal centers
Interféron de type I
Etiology
Interferon
Neuromuscular junction
MiR-7
Interferon IFN
Th17 cells
PBMC
Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype
Ectopic germinal centers
Interleukine-23
Myoblasts
Thymic epithelial cells
Maladie auto-immune
Gd T cells
Inflammation
Acetylcholine receptors
CD31
Antimir-150
Interferon type-I
Animal models
Myasthenia gravis
Lamin A/C nuclei
Myasthénie grave
Complete Freund's adjuvant
MiR-125
Early-onset myasthenia gravis
Thymoma
Anticorps monoclonal
Cardiomyopathy
Immunity
Experimental mouse models
B cells
COVID-19
MG patients
Immunology and Microbiology Section
Disease susceptibility
CTCF
Thymus
M3243AG
Auto-immunité
Glucocorticoids
LMNA
Heart failure
COX2
CCL21
Immunotherapy
Genetics
Endogenous nucleic acids
Acetylcholine receptor antibodies
Chemokines
Fragile X syndromes
Experimental autoimmune myasthenia gravis
Centres germinatifs ectopiques
CXCL13-CXCR5
Autoimmune diseases
Clinical cell transplantation
Gender
FMR1
Acetylcholine receptor
Interferon de type I
Autoimmunity
DICER
Il-23
Cellules th17
Immune regulation
Interferon-β
Chronicity
Quality of life
Conduction disease
Myasthenia Gravis MG
Inflammatory cytokines
Chronic inflammation
Acides nucléiques endogènes
Chemokine
Experimental models
Max
Long-term follow-up
Germinal center
Interleukin 23
Immune response
Adaptive immunity
Interferon type I
Mass cytometry CyTOF
AChR antibodies
Genetic associations
Human myoblasts
Cytokines
Ferrites